Home
>
US Stocks
>
Nuvation Bio Inc - Class A
Nuvation Bio Inc - Class A
NUVB

Nuvation Bio Inc - Class A

$9.562.45%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
9.62
Today Low/High
9.38 / 9.64
52 Week Low/High
$7.86 / $15.23
Market Cap
$1.91B

Company Details

Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world's leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco.
Organisation
Nuvation Bio Inc - Class A
Employees
36

Discover more

Frequently Asked Questions

What is Nuvation Bio Inc - Class A share price today

Can Indians buy Nuvation Bio Inc - Class A shares?

How can I buy Nuvation Bio Inc - Class A shares from India?

Can Fractional shares of Nuvation Bio Inc - Class A be purchased?

What are the documents required to start investing in Nuvation Bio Inc - Class A stocks?

We are a SEBI registered investement advisor